Lenalidomide versus thalidomide in myeloma

Comment: Advances in haematological cancer presented at EHA 2014

Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety?

History and ongoing work of AORTIC

AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya

Role of AORTIC in dealing with rising cancer rates in Africa

The global control and prevention of cervical cancer caused by HPV

Troubling differences in the success rates of breast cancer treatment across different countries

Deaths from breast cancer fall in Europe, but unexplained differences between countries remain

Significant UK variations between hospitals in adverse outcomes for DCIS

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

Cost constraints affect treatment decision-making in China and Singapore - expert discussion